Investigating the level of salivary endothelin ‐1 in premalignant and malignant lesions

ConclusionsThe level of salivary endothelin‐1 in patients with SCC and OLP was higher than that in healthy group. Thus, it can be used as the latest therapeutic protocol for oral premalignant and malignant lesions.
Source: Special Care in Dentistry - Category: Dentistry Authors: Tags: ARTICLE Source Type: research